About NAD(P)H pyrophosphatase NUDT13, mitochondrial
NAD(P)H pyrophosphatase NUDT13, mitochondrial (NUDT13) is a protein
from Homo sapiens identified by UniProt accession
Q86X67, 352 residues long.
MolForge cross-references it against 0 known binders and
27 disease associations.
Target properties
| Protein name | NAD(P)H pyrophosphatase NUDT13, mitochondrial |
| UniProt accession | Q86X67 |
| Gene | NUDT13 |
| Organism | Homo sapiens |
| Length | 352 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (27)
Diseases linked to this target (Open Targets).
- total cholesterol measurement · score 0.11
- systolic blood pressure · score 0.10
- serum alanine aminotransferase measurement · score 0.08
- body height · score 0.08
- reticulocyte measurement · score 0.07
- Familial exudative vitreoretinopathy · score 0.06
- X-linked retinal dysplasia · score 0.05
- severe early-childhood-onset retinal dystrophy · score 0.05
- MODY · score 0.05
- X-linked retinoschisis · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q86X67-F1 | alphafold | PREDICTED | 88.53 | — |
Amino-acid sequence (352 residues)
MSLYCGIACR RKFFWCYRLL STYVTKTRYL FELKEDDDAC KKAQQTGAFY LFHSLAPLLQ TSAHQYLAPR HSLLELERLL GKFGQDAQRI EDSVLIGCSE QQEAWFALDL GLDSSFSISA SLHKPEMETE LKGSFIELRK ALFQLNARDA SLLSTAQALL RWHDAHQFCS RSGQPTKKNV AGSKRVCPSN NIIYYPQMAP VAITLVSDGT RCLLARQSSF PKGMYSALAG FCDIGESVEE TIRREVAEEV GLEVESLQYY ASQHWPFPSG SLMIACHATV KPGQTEIQVN LRELETAAWF SHDEVATALK RKGPYTQQQN GTFPFWLPPK LAISHQLIKE WVEKQTCSSL PA
Explore NAD(P)H pyrophosphatase NUDT13, mitochondrial with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets